Gilteritinib Loaded Liposomes(Lipo-001RG)
| Product Summary | |
|---|---|
| Name | Gilteritinib Loaded Liposomes |
Download Datasheet
|
|
| Cat No. | Lipo-001RG |
| Product Overview | Gilteritinib (ASP2215) is a small-molecule FLT3/AXL inhibitor with IC50 values of 0.29 nM and 0.73 nM for FLT3 and AXL, respectively. It inhibits FLT3 at an IC50 value that was approximately 800-fold more potent than the concentration required to inhibit c-KIT (230 nM). This product is a PEG modified pre-formulated liposome with Gilteritinib (ASP2215) loaded. It is supplied ready to use in vitro or in vivo studies. The lipid composition is HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol). |
| Lipid Composition | HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) |
| Active Ingredients | Gilteritinib |
| Form | Liquid |
| Storage Buffer | DPBS (1X), pH 7.4 |
| Concentration | 2.5 mg/mL (Concentration Gilteritinib); Lipid Concentration 26.4 mM |
| Stability | At least 3 months |
| Storage | 2 °C to 8 °C (do not freeze), stored under nitrogen |
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
Can you provide information on the size and composition of your liposomes?
Yes, we offer detailed specifications for each product, enabling researchers to select liposomes that best match their experimental requirements.
-
Do you offer customization options for liposome formulations?
Yes, we offer customization services to meet the unique demands of research projects. Our team of experts can work with customers to develop custom liposome formulations tailored to their specific needs, ensuring optimal results for their experiments.
-
What analytical and characterization data do you provide with your liposome products?
We provide comprehensive analytical and characterization data for all our liposome products, such as size distribution, zeta potential, and encapsulation efficiency.
